icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
AASLD 2024
Nov 15-19,
San Diego, CA
Back grey_arrow_rt.gif
 
 
 
CHARACTERIZATION OF THE DIRECT ANTIVIRAL EFFECT OF REP 2139 IN 2D AND 3D HDV INFECTION MODELS
 
 
 
AASLD 2024 Nov 15-19 San Diego
 
S FONTE 1,2, ML PLISSONNIER 1,2, M MICHELET 1,2, A ROCA SUAREZ 1,2, A VAILLANT 3, M LEVRERO 1,2,4,5,6 1 IHU Lyon - Institute d'Hépatologie de Lyon, Lyon, France; 2 PathLiv UNIT UCLB1 & INSERM, Lyon, France; 3 Replicor Inc., Montreal, Canada; 4 Department of Hepatology, Hôpital Croix-Rousse, Hospices Civils de Lyon, Lyon, France; 5 University of Lyon Claude Bernard 1 (UCLB1), Lyon, France; 6 Department of Medicine SCIAC and the Italian Institute of Technology (IIT) Center for Life Nanosciences (CLNS), University of Rome La Sapienza, Rome, Italy

1211241

1211242

1211243

1211244

1211245

1211246

1211247

1211248

1211249

12112410

12112411